Tag: Radiotherapy
-
SUPREMO Trial: Rethinking Postmastectomy Radiotherapy
Overview: A Shift in Postmastectomy Strategy The international phase 3 SUPREMO trial is reshaping how clinicians treat intermediate-risk early breast cancer (eBC) after mastectomy. The study, officially registered as ISRCTN61145589, investigated whether omitting chest-wall irradiation could maintain survival outcomes while reducing treatment-related toxicity. Historically, postmastectomy radiotherapy (PMRT) has been standard care for various levels of…
-
In Focus: Late Detection of Prostate Cancer and the PSA Blood Test
Understanding Why Prostate Cancer Often Surfaces Late Prostate cancer is one of the most common cancers among men, yet it remains a disease that many people fear or misunderstand. A key issue is late detection. While some tumors grow slowly and cause few symptoms, others advance quietly until they are harder to treat. Delays in…
-
In Focus: Late Detection of Prostate Cancer and the PSA Test Debate
Understanding the PSA Test and Why It Matters Prostate cancer is a leading health concern for men, and early detection can dramatically change outcomes. The prostate-specific antigen (PSA) blood test is a common screening tool used to flag potential trouble in the prostate. Yet many men—and some clinicians—are hesitant about routine PSA testing. Concerns about…
-
In Focus: Why Men Skip the PSA Blood Test for Prostate Cancer and What Happens Next
Understanding the PSA Test and Early Detection The PSA (prostate-specific antigen) blood test is a simple screening tool designed to help detect potential prostate cancer before symptoms appear. Because the disease can progress quietly, early detection often leads to more treatment options and better outcomes. Yet, many men delay or decline PSA testing for a…
-
Global Analysis Reveals Stark Inequalities in Care for Breast, Cervical, and Ovarian Cancers
New Global Findings Highlight Widespread Inequities in Cancer Care A landmark study by the Cancer Survival Group at the London School of Hygiene & Tropical Medicine reveals persistent and troubling inequalities in how women’s cancers—breast, cervical, and ovarian—are diagnosed and treated around the world. The research, which analyzed data from diverse health systems, shows that…
-
Pembrolizumab Doubles Survival in Advanced Head and Neck Cancer
The Breakthrough: A New Immunotherapy Redefines Outcomes in Locally Advanced Head and Neck Cancer Locally advanced head and neck cancer poses a formidable challenge. In many patients, the disease is detected at a stage where surgery, radiotherapy, and chemotherapy are the mainstays of treatment, yet recurrence and progression remain common. A recent advance in immunotherapy,…
-
Radiopharmaceutical Therapy Boosts Radiation in Prostate Cancer
LUNAR Trial: Combining Radiopharmaceutical Therapy with SBRT A phase II study known as the LUNAR trial investigated whether adding a PSMA-targeted radiopharmaceutical before high-precision radiation could improve outcomes for men with oligometastatic, hormone-sensitive recurrent prostate cancer. In this randomized study, 92 participants with one to five distant lesions visible on PSMA PET/CT were assigned to…
-
New Radiotherapy Sector Opens at CHU Bordeaux for Patient Care
A Major Advancement in Patient Care The CHU de Bordeaux has taken a significant step forward in enhancing patient experiences by inaugurating a new sector of radiotherapy at the Haut-Lévêque Hospital in Pessac. This launch, which took place on September 10, marks a pivotal moment for the hospital and its commitment to improving the quality…
-
CHU de Bordeaux Inaugurates New Radiotherapy Sector
Introduction to the New Radiotherapy Sector On September 10th, a significant milestone was achieved at the CHU de Bordeaux with the inauguration of a new ambulatory radiotherapy sector located within the Haut-Lévêque Hospital in Pessac. This state-of-the-art facility aims to enhance patient care and improve the quality of life for individuals undergoing cancer treatment. Enhancing…
-
CHU de Bordeaux Inaugurates New Radiotherapy Sector for Patients
Introduction to the New Radiotherapy Sector The CHU de Bordeaux has made a significant advancement in enhancing the quality of patient care with the inauguration of a new radiotherapy sector. On September 10, the hospital hosted a ceremony at the Haut-Lévêque hospital in Pessac, showcasing its commitment to providing cutting-edge medical services. Why Radiotherapy Matters…